Discovery and research of new molecular compounds are expensive, with development costsin some cases. Part of that comes from the relevant molecule, studying its chemical composition, interactions, and physical structure at the atomic level. Despite advances in software to help model these compounds and molecules, there are still challenges in fully understanding their shapes through a two-dimensional computer screen.
San Diego-based startup. The idea for Nanome came from in the nanoengineering program at UC San Diego, where he saw a need for a better understanding of three-dimensional molecular structures.
“Understanding structure empowers ourfunction,” he wrote in an email. “Yet, the R&D process for drug discovery relies on 2D monitors, keyboard, and mouse, which limits the understanding of complex 3D structures or interactions and contributes to massive R&D costs averaging $2.5B per drug.”
Nanome recently closed a funding round led byfor $3 million to establish new business partnerships, build its brand, and expand its science and engineering team. “Nanome is reimagining the way we in collaboration is more important than ever before,” said Bullpen Capital General Partner Ann Lai in a press release. , led by Oculus co-founder Michael Antonov, also participated in the round.
McCloskey thinks Nanome’s platform has become even more relevant during the, as researchers might be forced to work remotely occasionally, limiting their access to in-lab technology and software.
“Nanome helps scientists get on the same page quicker,” he wrote in an email. “Traditionally, scientists working with molecules use screenshots orand rely on the mouse cursor and Zoom to communicate their insights and ask for feedback from other team members.” Nanome streamlines this process by bringing researchers to the same virtual reality space to work on molecule development together.
So far, Nanome has mainly worked on projects with companies in the food and beverageand another to develop more sustainable batteries. But they have into pharmaceutical chemistry, synthetic biology, and even education. Their next product what McCloskey calls ‘Spatial Recording,’ allowing users to record their work for later review – a screen recording but with a VR experience. “This is not only an amazing among researchers, but it is also useful for producing lectures and lessons,” he wrote in an email.